Mannkind (MNKD) Non-Current Deffered Revenue (2017 - 2026)

Mannkind (MNKD) reported Non-Current Deffered Revenue of $38.9 million for Q1 2026, down 17.85% year-over-year from $47.4 million in Q1 2025, and down 2.68% quarter-over-quarter from $40.0 million in Q4 2025.

Mannkind (MNKD) Non-Current Deffered Revenue (2017 - 2026) Analysis & Trends

Mannkind (MNKD) has 10 years of Non-Current Deffered Revenue data on file, last reported at $38.9 million in Q1 2026.

  • Non-Current Deffered Revenue for Q1 2026 came in at $38.9 million, down 17.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $38.9 million (down 17.85% YoY), and the FY2025 annual result was $40.0 million, down 21.86% from the prior year.
  • Non-Current Deffered Revenue eased to $38.9 million in Q1 2026 per MNKD's latest filing, from $40.0 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $69.8 million in Q4 2023 and troughed at $1.2 million in Q1 2023.
  • A 5-year average of $46.8 million and a median of $47.4 million in 2025 frame the typical range for Non-Current Deffered Revenue.
  • The sharpest annual moves came in 2023 and 2024: Non-Current Deffered Revenue plunged 95.41% in 2023, then jumped 5545.08% in 2024.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $37.7 million in 2022, then jumped by 85.21% to $69.8 million in 2023, then dropped by 26.7% to $51.2 million in 2024, then fell by 21.86% to $40.0 million in 2025, then dropped by 2.68% to $38.9 million in 2026.
  • Business Quant data shows MNKD's Non-Current Deffered Revenue at $38.9 million in Q1 2026, $40.0 million in Q4 2025, and $48.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Mannkind 1.21 Bn 1.08 Bn 82.66 Mn 38.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 38.91 Mn
Dec 31, 2025 39.98 Mn
Sep 30, 2025 48.19 Mn
Jun 30, 2025 45.47 Mn
Mar 31, 2025 47.36 Mn
Dec 31, 2024 51.16 Mn
Sep 30, 2024 65.15 Mn
Jun 30, 2024 66.12 Mn
Mar 31, 2024 67.74 Mn
Dec 31, 2023 69.79 Mn
Sep 30, 2023 69.47 Mn
Jun 30, 2023 60.25 Mn
Mar 31, 2023 1.20 Mn
Dec 31, 2022 37.68 Mn
Sep 30, 2022 32.00 Mn
Jun 30, 2022 29.76 Mn
Mar 31, 2022 26.12 Mn
Dec 31, 2021 19.54 Mn
Sep 30, 2021 1.55 Mn
Jun 30, 2021 1.59 Mn